- Home
- ALLR vs PRSO Comparison
ALLR vs PRSO Comparison
Compare ALLR & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- PRSO
- Stock Information
- Founded
- ALLR 2004
- PRSO 2008
- Country
- ALLR United States
- PRSO United States
- Employees
- ALLR N/A
- PRSO N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- ALLR Health Care
- PRSO Technology
- Exchange
- ALLR Nasdaq
- PRSO Nasdaq
- Market Cap
- ALLR 13.3M
- PRSO 4.3M
- IPO Year
- ALLR N/A
- PRSO 2001
- Fundamental
- Price
- ALLR $0.90
- PRSO $1.07
- Analyst Decision
- ALLR
- PRSO Buy
- Analyst Count
- ALLR 0
- PRSO 1
- Target Price
- ALLR N/A
- PRSO $3.00
- AVG Volume (30 Days)
- ALLR 453.6K
- PRSO 339.9K
- Earning Date
- ALLR 08-04-2025
- PRSO 08-11-2025
- Dividend Yield
- ALLR N/A
- PRSO N/A
- EPS Growth
- ALLR N/A
- PRSO N/A
- EPS
- ALLR N/A
- PRSO N/A
- Revenue
- ALLR N/A
- PRSO $15,626,000.00
- Revenue This Year
- ALLR N/A
- PRSO $3.96
- Revenue Next Year
- ALLR N/A
- PRSO $36.80
- P/E Ratio
- ALLR N/A
- PRSO N/A
- Revenue Growth
- ALLR N/A
- PRSO 35.50
- 52 Week Low
- ALLR $0.61
- PRSO $0.52
- 52 Week High
- ALLR $14.25
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- ALLR 49.46
- PRSO 52.96
- Support Level
- ALLR $0.80
- PRSO $1.09
- Resistance Level
- ALLR $0.98
- PRSO $1.31
- Average True Range (ATR)
- ALLR 0.06
- PRSO 0.15
- MACD
- ALLR 0.01
- PRSO -0.01
- Stochastic Oscillator
- ALLR 61.93
- PRSO 32.79
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.